Am J Clin Pathol. 2015 Nov;144(5):713-21
Nature. 2015 Oct 19;
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients.
J Neurooncol. 2015 Oct 17;
Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting.
Oncotarget. 2015 Aug 19;
Distinct Pathways in the Pathogenesis of Sebaceous Carcinomas Implicated by Differentially Expressed MicroRNAs.
JAMA Ophthalmol. 2015 Jul 23;
Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy.
Mod Pathol. 2015 Jun 26;
Macitentan, a dual endothelin receptor antagonist, in combination with temozolomide leads to glioblastoma regression and long-term survival in mice.
Clin Cancer Res. 2015 Jun 23;
DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status.
Acta Neuropathol Commun. 2015;3:34
Acta Neuropathol. 2015 Jun 19;